WAS
EDSA icon

WESPAC Advisors SoCal’s Edesa Biotech EDSA Stock Holding History

WESPAC Advisors SoCal’s Portfolio EDSA Stock Details EDSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-7
Closed – – 144
2019
Q1 		$0 Hold
7
– – ﹤0.01% 341
2018
Q4 		$0 Hold
7
– – ﹤0.01% 341
2018
Q3 		$0 Buy
+7
New +$446 ﹤0.01% 309
2018
Q2 		– Sell
-7
Closed -$1K – 128
2018
Q1 		$1K Hold
7
– – ﹤0.01% 255
2017
Q4 		$1K Hold
7
– – ﹤0.01% 240
2017
Q3 		$2K Hold
7
– – ﹤0.01% 243
2017
Q2 		$2K Hold
7
– – ﹤0.01% 224
2017
Q1 		$3.26K Hold
7
– – ﹤0.01% 221
2016
Q4 		$4.06K Buy
+7
New +$4.31K ﹤0.01% 221

Other funds holding EDSA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

WESPAC Advisors SoCal's EDSA Position: Q2 2019 in Review

WESPAC Advisors SoCal sold out of Edesa Biotech (EDSA) in Q2 2019, closing a stake of 7 shares.

WESPAC Advisors SoCal first reported a position in EDSA in Q4 2016 and held it in 9 quarters. The position peaked at $4.06K in Q4 2016. 8 funds tracked by Wall St. Rank hold EDSA as of Q2 2019.

  • WESPAC Advisors SoCal reported no remaining Edesa Biotech position as of Q2 2019 after selling out during the quarter.
  • WESPAC Advisors SoCal sold 7 Edesa Biotech shares in Q2 2019.
  • WESPAC Advisors SoCal first reported a position in Edesa Biotech in Q4 2016 and held it in 9 quarters.
  • WESPAC Advisors SoCal's Edesa Biotech position peaked at $4.06K in Q4 2016.
  • 8 funds tracked by Wall St. Rank held Edesa Biotech as of Q2 2019.

Based on WESPAC Advisors SoCal's 13F filing for Q2 2019, filed 30 Jul 2019.